Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 diabetes trial.
Retatrutide Leads Ozempic in Weight Loss in New Diabetes Trial
Lilly reports that retatrutide achieved greater weight loss and blood sugar reduction than Ozempic 2 mg in an 80-week type 2 diabetes trial.